bioMerieux (OTCMKTS:BMXMF) Sees Strong Trading Volume – Here’s What Happened

bioMerieux (OTCMKTS:BMXMF) saw strong trading volume on Friday . 137 shares traded hands during mid-day trading, an increase of 37% from the previous session’s volume of 100 shares.The stock last traded at $110.00 and had previously closed at $112.57.

Analyst Upgrades and Downgrades

Separately, BNP Paribas Exane cut bioMerieux to a “neutral” rating in a research note on Wednesday, January 28th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, bioMerieux has an average rating of “Hold”.

bioMerieux Price Performance

The company has a fifty day moving average of $122.08 and a two-hundred day moving average of $129.38. The company has a quick ratio of 1.30, a current ratio of 2.27 and a debt-to-equity ratio of 0.08.

bioMerieux Company Profile

bioMérieux is a global leader in in vitro diagnostics, specializing in the development, manufacture and distribution of diagnostic solutions that determine the source of disease and contamination to improve patient health and ensure consumer safety. The company’s product portfolio encompasses a broad range of assays and instruments for microbiological and immunoassay testing, including molecular diagnostics for infectious diseases, immunoassays for autoimmune and oncology markers, and traditional microbial identification and antimicrobial susceptibility testing.